TruaceTracing the truth around AITuesday, September 15, 2026
The Index

What the evidence says.What the public feels.

Ranks distinct AI gain and problem claims from the published record. Scores reward impact, independent source strength, scale, confidence, and recency.

1,419 results
Show filters and sorting

AI gains · 788

68
GainHealth· Stable· Evidence: Moderate (1 source)

AI integration in echocardiography workflows reduces examination time and automates measurements, enabling more comprehensive data collection while reducing sonographer fatigue.

A review published August 26, 2026 describes echocardiography workflows transitioning from manual acquisition and measurement to AI-driven interpretation, citing prospective evaluations where AI reduces examination time, automates measurements, and supports integrated assessments of ejection fraction, myocardial texture, and Doppler hemodynamics.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%96

Updated Aug 28, 2026 · TRV-2026-0913

68
GainHealth· Stable· Evidence: Moderate (1 source)

Naive CD4+ TCR repertoire features enabled moderate machine-learning classification of celiac disease status and high-accuracy prediction of HLA-DQ2.5 status by publication date.

The study used machine learning on naive CD4+ TCR and naive BCR AIRR-seq repertoires to test classification of celiac disease versus controls, building on prior work linking germline HLA variation to naive repertoire composition and earlier BCR-based classification attempts.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%96

Updated Aug 28, 2026 · TRV-2026-0912

68
GainHealth· Stable· Evidence: Moderate (1 source)

Automated AI quantification of pulmonary artery-to-vein volume difference achieved the highest discrimination for high/intermediate-high risk acute pulmonary embolism with low missed-diagnosis risk.

Researchers retrospectively analyzed 134 acute pulmonary embolism cases from April 2023 to March 2024, using commercial AI software to automatically measure a new biomarker, pulmonary artery-to-vein volume difference, alongside traditional CTPA parameters to stratify high/intermediate-high versus lower risk.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%96

Updated Aug 27, 2026 · TRV-2026-0909

68
GainHealth· Stable· Evidence: Moderate (1 source)

Transfer learning enhanced AI lesion detection performance when models were adapted from one regional DBT database to another.

A study tested YOLO-based AI models for breast lesion detection on digital breast tomosynthesis using a 94-patient Western database from the Cancer Imaging Archive and a 157-patient Eastern database from a single medical center, with lesions grouped into six types.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%96

Updated Aug 27, 2026 · TRV-2026-0908

AI problems · 631

68
ProblemPolicy· Stable· Evidence: Moderate (1 source)

Current automated and human moderation systems on Roblox fail to prevent young users' exposure to inappropriate content, cyberbullying, and predatory behavior.

Published 25 April 2025, this peer-reviewed case study examines Roblox as a child-focused Metaverse platform, analyzing why automated and human moderation struggles with real-time interactions and massive volumes of user-generated content and documenting failures that left young users exposed to inappropriate content and predatory risks.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%90

Updated Jul 24, 2026 · TRV-2026-0536

68
ProblemHealth· Stable· Evidence: Moderate (1 source)

ML-enhanced point-of-care testing faces regulatory hurdles, reliability questions, and privacy concerns that limit widespread clinical adoption.

Published April 2, 2025 in Nature Communications, this Perspective examines how machine learning is being integrated into decentralized point-of-care testing platforms, including lateral flow, vertical flow, nucleic acid amplification, and imaging-based sensors, following a pandemic-driven shift away from centralized labs.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%90

Updated Jul 24, 2026 · TRV-2026-0532

68
ProblemHealth· Stable· Evidence: Moderate (1 source)

Medical LLMs still face numerous challenges in practical applications, including hallucination, limited interpretability, and ethical concerns that hinder widespread use.

This review describes the rapid development of large language models such as GPT-4 and their growing use in medicine. By May 2025, the authors state that LLMs have been gradually implemented in clinical practice, medical research, and medical education, while still facing challenges of hallucination, interpretability, and ethics.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%90

Updated Jul 24, 2026 · TRV-2026-0526

68
ProblemLabor· Rising· Evidence: Moderate (1 source)

People who use AI at work receive negative social evaluations about their competence and motivation, which can harm job candidate assessments.

In four preregistered experiments with 4,439 participants, researchers tested how people who use AI tools at work are perceived. They found that AI users expect to be judged negatively and that observers do rate them lower on competence and motivation, with those judgments spilling over into hiring-related assessments.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%90

Updated Jul 24, 2026 · TRV-2026-0525

Recomputed live from the record · Sep 15, 2026, 9:28 PM